Alex Azar, a former top executive at Eli Lilly and Co. and top official at the U.S. Department of Health and Human Services, has been tapped by President Trump to head HHS.
Max Richtman, president and CEO of the National Committee to Preserve Social Security and Medicare: “This is an ironic choice for a president who has pledged to lower prescription drug prices.”
via USA Today.
- As President of Eli Lilly, Azar presided over frequent price hikes on medications that seniors on fixed incomes depend upon. In fact, the company is currently being sued for fixing the price of insulin.
- Equally discouraging is Azar’s support of reckless legislation to repeal and replace the Affordable Care Act.